长非编码RNADGCR5在癌症中的作用:专注于分子标
Sulieman I S Al-Hawary1, Paul Rodrigues2, Harun Bangali2
1Department of Medicine, Al al-Bayt University, Mafraq, Jordan.
Cell biochemistry and function
|February 21, 2024
概括
长非编码RNADGCR5显示出作为癌症生物标志物和治疗点的前景. 需要进一步的研究,包括可靠的动物模型,以验证其在癌症诊断,预后和治疗的临床应用中的潜力.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 在瘤学瘤学.
背景情况:
- 长非编码RNAs (lncRNAs) 在细胞通路和癌症中至关重要.
- lncRNA DGCR5在各种癌症中表现出特定的表达模式.
- lncRNAs为癌症诊断,预后和治疗提供了潜力.
研究的目的:
- 审查最近有关lncRNA DGCR5作为癌症生物标记物的潜力的出版物.
- 探索DGCR5作为癌症治疗中的治疗点.
- 突出需要进一步的研究和可靠的动物模型DGCR5.
主要方法:
- 汇编和分析最近的科学文献.
- 对研究DGCR5在癌症中的表达和功能的研究进行了综述.
- 检查与DGCR5.5相关的临床试验数据.
主要成果:
- lncRNA DGCR5 作为潜在的癌症生物标志物,具有很高的特异性和准确性.
- 为了诊断和预后目的,可以非侵入性地提取DGCR5.
- 新出现的证据表明,DGCR5作为临床试验中的治疗点.
结论:
- lncRNA DGCR5在改善癌症诊断,预后和治疗方面具有重大前景.
- 通过更大的研究和适当的动物模型进行进一步验证是必不可少的.
- 对于未来的癌症治疗策略的DGCR5影响需要继续调查.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Small GTPases - Ras and Rho
4.0K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K


